RECRUITING

Time-Restricted Eating for Type II Diabetes: TRE-T2D

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a randomized clinical trial to assess the feasibility and efficacy of time-restricted eating (TRE) to improve glucose regulation and cardiovascular health of participants with type 2 diabetes mellitus (T2DM). Participants will be randomized into 2 groups: 1) standard of care (SOC), in which they will continue to follow their physician's treatment plan, or 2) SOC and TRE (8-10 hours eating window).

Official Title

Feasibility and Efficacy of Time-Restricted Eating in Diabetes Management

Quick Facts

Study Start:2022-05-16
Study Completion:2026-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05365529

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 75 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Justina P Nguyen, BS
CONTACT
858-246-2406
preventivecvresearch@health.ucsd.edu
David T Van, BS
CONTACT
858-246-2342

Principal Investigator

Pam Taub, MD
PRINCIPAL_INVESTIGATOR
Professor of Medicine

Study Locations (Sites)

Altman Clinical and Translational Research Institute
La Jolla, California, 92093
United States

Collaborators and Investigators

Sponsor: University of California, San Diego

  • Pam Taub, MD, PRINCIPAL_INVESTIGATOR, Professor of Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-05-16
Study Completion Date2026-03

Study Record Updates

Study Start Date2022-05-16
Study Completion Date2026-03

Terms related to this study

Additional Relevant MeSH Terms

  • Diabetes Mellitus, Type 2
  • Time Restricted Feeding
  • Diabetes Type2